WO2002102393A1 - Composition pour traiter une varicosite, et son procede de preparation - Google Patents

Composition pour traiter une varicosite, et son procede de preparation Download PDF

Info

Publication number
WO2002102393A1
WO2002102393A1 PCT/CN2001/001551 CN0101551W WO02102393A1 WO 2002102393 A1 WO2002102393 A1 WO 2002102393A1 CN 0101551 W CN0101551 W CN 0101551W WO 02102393 A1 WO02102393 A1 WO 02102393A1
Authority
WO
WIPO (PCT)
Prior art keywords
medicine
varicose
contractile
vitamin
spirit
Prior art date
Application number
PCT/CN2001/001551
Other languages
English (en)
Chinese (zh)
Inventor
Yuchang Wang
Original Assignee
Yuchang Wang
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yuchang Wang filed Critical Yuchang Wang
Publication of WO2002102393A1 publication Critical patent/WO2002102393A1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • A61K31/51—Thiamines, e.g. vitamin B1
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A61K36/484—Glycyrrhiza (licorice)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers

Definitions

  • the invention relates to an injection medicine for treating varicose veins, in particular to a varicose vein contraction spirit and a preparation method thereof.
  • Varicose vein disease mostly occurs in the lower limbs of the human body, and is named because the superficial veins of the human body become thicker, longer, and bent; due to people's overwork, long standing, cold, pregnancy, etc., some venous valve stagnation of the lower limbs cannot be closed normally.
  • the local venous pressure is increased; for the treatment of varicose veins, the medical community has been using traditional treatment methods for decades. It has been to extract or ligate varicose vein tissue, or inject sclerosant to block varicose veins.
  • Methods Patients are traumatized, easily cause bleeding, and cause some pain to patients. At the same time, quite a lot of patients have more difficulty in lower limb blood circulation after surgery.
  • Some patients have severe recurrence after compensation, or they are afraid of cold due to insufficient blood supply to the lower limb Numbness, or increased swelling of the affected limb, or secondary phlebitis, and development of chronic ulcers that are difficult to treat for life.
  • the designer of the present invention relies on many years of clinical experience, and based on repeated research and demonstration, the combination of traditional Chinese and western medicine finally produces the present invention.
  • the object of the present invention is to overcome the deficiencies of the prior art described above, and provide a varicose vein contraction spirit and a method for making the same, a simple, easy-to-use, and highly effective varicose vein contraction injection drug.
  • a kind of varicose contractile spirit which is characterized in that: it uses aluminum potassium sulfate as its main ingredient, The solution is used as a solvent, and supplemented with vitamin V, B1, licorice, and green leaf extract.
  • the formulation for varicose contractile injection is:
  • the varicose vein contraction spirit of the present invention is a compound preparation with reasonable pH and no toxic and side effects. When used, it is injected intravenously into the local local lesions of the human body. It can be cured in one time, with an effective rate of 100% and a cure rate of more than 95%. After treatment, the skin is intact, and the uneven curvature is restored to the original natural phenomenon of soft, smooth and smooth skin, sensitive and color. Efficacy. Examples of the invention
  • the formulation of the present invention when configured according to a portion of varicose contractile injection is:
  • Vc (Vitamin C) 0. 03-0. 05g B1 (Vitamin B1) 0. 02-0. 03g Potassium aluminum sulfate 0. 3g Large green leaves and licorice boiled and dried face dose of 0.03g and then chlorinated
  • the medical mixture of 5 g of sodium medical solution is diluted to a total of 0.36 g to 0.41 g of the drug mixture.
  • the manufacturing method of varicose veins is:
  • the above-mentioned mixed medicine is fried in a decoction machine, and then the fried medicine liquid is added to an alcohol to precipitate and extract alcohol, and then placed in a dryer to dry it to make a dough;

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Botany (AREA)
  • Cardiology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Vascular Medicine (AREA)
  • Mycology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

L'invention concerne une composition destinée au traitement d'une varicosité, laquelle contient du sulfate de potassium d'aluminium comme principe actif, une solution saline comme solvant, combinés avec de la vitamine C et de la vitamine B1, ainsi qu'un extrait de réglisse et d'herbe taching. La composition selon la présente invention est une formulation complexe dont le pH est adapté mais qui n'a pas d'effets secondaires. On l'administre facilement par injection dans la zone affectée, sans provoquer de douleur chez le patient. Après injection d'une seule dose ou d'une double dose, la varicosité est traitée avec une efficacité de 100 % ou avec un taux de guérison supérieur à 95 %, et la peau affectée retrouve la même douceur et la même sensibilité qu'avant son affection.
PCT/CN2001/001551 2001-06-14 2001-11-13 Composition pour traiter une varicosite, et son procede de preparation WO2002102393A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CN01129207.5 2001-06-14
CN01129207A CN1126562C (zh) 2001-06-14 2001-06-14 治疗静脉曲张的制剂及其制作方法

Publications (1)

Publication Number Publication Date
WO2002102393A1 true WO2002102393A1 (fr) 2002-12-27

Family

ID=4668999

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/CN2001/001551 WO2002102393A1 (fr) 2001-06-14 2001-11-13 Composition pour traiter une varicosite, et son procede de preparation

Country Status (2)

Country Link
CN (1) CN1126562C (fr)
WO (1) WO2002102393A1 (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115079659A (zh) * 2022-08-23 2022-09-20 山东昊福药业集团制药有限公司 中药生产浓缩过程中蒸发速度的数字化控制方法及系统

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1043628A (zh) * 1987-02-09 1990-07-11 拉斯兹洛·汉科 缓解静脉扩张的组合物及其制备方法
US5206016A (en) * 1991-11-14 1993-04-27 Florin Vegyipari Szovetkezet Cream containing aluminum potassium sulfate and process for preparing same
CN1228335A (zh) * 1999-01-26 1999-09-15 韩葆凌 用于跌打损伤的红花外用软膏

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1043628A (zh) * 1987-02-09 1990-07-11 拉斯兹洛·汉科 缓解静脉扩张的组合物及其制备方法
US5206016A (en) * 1991-11-14 1993-04-27 Florin Vegyipari Szovetkezet Cream containing aluminum potassium sulfate and process for preparing same
CN1228335A (zh) * 1999-01-26 1999-09-15 韩葆凌 用于跌打损伤的红花外用软膏

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115079659A (zh) * 2022-08-23 2022-09-20 山东昊福药业集团制药有限公司 中药生产浓缩过程中蒸发速度的数字化控制方法及系统
CN115079659B (zh) * 2022-08-23 2022-12-06 山东昊福药业集团制药有限公司 中药生产浓缩过程中蒸发速度的数字化控制方法及系统

Also Published As

Publication number Publication date
CN1326781A (zh) 2001-12-19
CN1126562C (zh) 2003-11-05

Similar Documents

Publication Publication Date Title
CN110693977A (zh) 一种治疗早泄和勃起功能障碍的外用中药及其制备方法
CN104825941B (zh) 一种治疗脚气的中草药组合物及其制备方法
CN110075258A (zh) 一种糖尿病足溃疡外用药
CN103977113A (zh) 一种治疗糖尿病足的中药
WO2002102393A1 (fr) Composition pour traiter une varicosite, et son procede de preparation
CN106110032B (zh) 一种治疗慢性复发性口腔溃疡的中药
CN101934016B (zh) 一种治疗关节炎的外用药
CN108704041A (zh) 一种鼻炎贴及其制备方法
CN104623217A (zh) 一种治疗哮喘的中药制剂及制备方法
CN103127483B (zh) 一种治疗脉管炎的外敷药及其制备方法
CN108404085A (zh) 一种用于感冒的中药贴配方及其制备方法
CN107802752A (zh) 一种治疗复发性口腔溃疡的汤剂药物及其制备方法
CN106110121A (zh) 一种治疗花斑癣的中药组合物
CN105560581A (zh) 医治冻疮的中药酊及其制法
CN106177572A (zh) 一种治疗再生障碍性贫血的中药汤剂
CN104367896A (zh) 一种治疗气虚血瘀型中风的药物组合物及其制备方法
CN105456995A (zh) 一种治疗新生儿黄疸的中药组合物
CN104491537A (zh) 一种治疗风湿性心脏病的中药组合物
CN104491211A (zh) 一种治疗静脉性溃疡的中药配方
CN103948804B (zh) 一种治疗肺气虚型夏季皮炎的中药组合物
CN104706902A (zh) 一种治疗过敏性鼻炎的中药组合物
CN104189191B (zh) 皮肤癣疾中药药浴及制备方法
CN102579732B (zh) 一种治疗股骨头坏死的药膏及制备方法
CN103272035B (zh) 一种治疗脱疽的药物
CN107496626A (zh) 一种用于治疗鼻塞的丸剂药物及其制备方法

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CO CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
121 Ep: the epo has been informed by wipo that ep was designated in this application
REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP

WWW Wipo information: withdrawn in national office

Country of ref document: JP